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Summary 
 
Background. The i-gel (Intersurgical Ltd) is a novel device that differs from other 
supraglottic airway devices currently in use in that it has a softer and a non-inflatable 
cuff. Our study was designed to assess whether the i-gel is suitable to provide 
pressure-controlled ventilation (PCV) during anaesthesia by measuring the gas leaks 
and comparing these values with that of the tracheal tube. 
 
Methods. Twenty five patients with ASA physical status 1-2 were recruited to the 
study. Patients received a standard anaesthetic technique followed by an initial 
placement of the i-gel. The lungs were then ventilated at three different pressures (15, 
20, 25 cm H2O) using PCV. The difference between the inspired and expired tidal 
volumes was used to calculate the leak volume. The leak fraction was defined as the 
leak volume divided by the inspired tidal volume. Following these observations the i-
gel was removed and replaced with the conventional tracheal tube and the recordings 
repeated.  
 
Results. There was no statistically significant difference between the leak fractions of 
the i-gel and the tracheal tube at 15 and 20 cm H2O PCV. At 25 cm H2O PCV the 
median difference in leak fraction was 0.02 (p=0.014) and the median difference in 
leak volume was 26.5 ml (p=0.006). There was no evidence of gastric insufflations 
with any of the pressures used during PCV. 
     
Conclusion. The data from our study suggests that the i-gel can be used as a 
reasonable alternative to tracheal tube for a vast majority of patients to provide PCV. 
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Laryngeal mask airways (LMAs) are routinely used during anaesthesia for 
spontaneously breathing patients. LMAs are also used to ventilate patients’ lungs 
during anaesthesia but may be associated with a less effective seal compared to the 
conventional tracheal tubes.1 The i-gel (Intersurgical Ltd, Crane House, Molly Millars 
Lane, Wokingham, Berkshire) is a novel supraglottic airway device made of 
thermoplastic elastomer which is soft, gel-like and transparent. Unlike the 
conventional LMA it does not have an inflatable cuff. Cadaver studies have shown 
that i-gels effectively conformed to the perilaryngeal anatomy and consistently 
achieved proper positioning for supraglottic ventilation.2 Studies performed on 
manikins and patients have shown that the insertion of the i-gel was significantly 
easier when compared to insertion of other supraglottic airway devices available on 
the market.3 4 Furthermore, there is evidence to suggest that it is easier to train non-
anaesthetists how to correctly insert i-gels, compared to the conventional supraglottic 
airway devices, thus making it a potentially useful device for situations such as 
resuscitation.5 6 The i-gel may also have a role in management of  the difficult airway 
as there are case reports of fibreoptic intubations being successfully preformed with 
the aid of the i-gel.7 8 Recent studies support its use during anaesthesia for 
spontaneously breathing patients.9-11 There are currently no published studies showing 
that the i-gel provides a good seal during pressure-controlled ventilation (PCV). Our 
study was designed to assess whether the i-gel is a suitable airway device to ventilate 
patients’ lungs while using PCV during anaesthesia. 
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Methods 
After obtaining approval from the Local Research Ethics committee and written 
informed consent, we aimed to recruit 20 adult patients. Patients scheduled for 
elective surgery that ordinarily involves tracheal intubation were recruited to the 
study. Most of our participants were undergoing abdominal hysterectomy or 
laparoscopic cholecystectomy. Patients with ASA physical status 1 or 2 between the 
age of 16 to 70 years, who had the ability to give informed consent, were included in 
the study. Patient exclusion criteria included (1) presence of any significant acute or 
chronic lung disease, or pathology of the neck or upper respiratory tract; (2) potential 
difficult intubation; (3) an increased risk of aspiration (hiatus hernia, 
gastroeosophageal reflux, full stomach); (4) pregnant women; (5) body mass index 
greater than 35 kg.m-2 and (6) patients unable to communicate in English. 
 
We used Datex-Ohmeda Aestiva/5 anaesthetic machines (GE Healthcare) with its 
built-in spirometer and pressure gauge for the study. Before induction of anaesthesia, 
the anaesthetic machine and circuits were checked as per manufacturers’ guidelines. 
Intravenous access was secured and standard monitors, including a peripheral nerve 
stimulator, were attached. After pre-oxygenation, anaesthesia was induced with 
fentanyl 1 microgram.kg-1 and a target control infusion (TCI) of propofol to achieve a 
target plasma concentration of propofol to 4-7 microgram.ml-1. Once loss of verbal 
contact was achieved, the anaesthetist checked that the patient could be hand 
ventilated with a facemask. A bolus dose of rocuronium (0.5 mg.kg-1) was then given. 
Neuromuscular blockade was confirmed using a train-of-four stimulation count 
(TOF=0). The anaesthetist then inserted the i-gel in accordance with manufacturer’s 
guidelines. Size selection of the i-gel depended on patient weight, Size 3 was used for 
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patients less than 50 kg, size 4 was used for those between 50 and 90 kg, and size 5 
was used for those over 90 kg in weight. Adequate placement of the device was 
assessed by gently squeezing the reservoir bag and observing the end-tidal carbon 
dioxide waveform and chest movements. If ventilation was inadequate, the following 
manipulations were allowed: gentle pushing or pulling of the device, chin lift, jaw 
thrust, head extension or neck flexion. The number of attempts required for insertion 
was recorded. A “failed attempt” was defined as removal of the device from the 
mouth before re-insertion. If the device was not successfully inserted by the second 
attempt, this was recorded as a failure of the i-gel. TCI propofol with oxygen-enriched 
air was used for maintenance of anaesthesia during data collection. Once a clear 
airway was established, the lungs were ventilated at three different pressures (15, 20, 
25 cm H2O) using PCV at a rate of 10 breaths per minutes and an inspiratory-to-
expiratory ratio of 1:2 with no positive end expiratory pressure. Inspired and expired 
tidal volumes were recorded. Measurements were taken over 10 breaths for each 
pressure setting. Gastric insufflation was assessed by auscultation over the patient’s 
epigastric area. Airway leak tests were then preformed. The fresh gas flow was 
adjusted to 3 litre.min-1 and the adjustable pressure limiting (APL) valve of the circle 
system was completely closed. Airway pressures were not allowed to exceed 40 cm 
H2O 
 
• Test 1 (auscultation) measuring the minimal airway pressure at which an 
audible gas leak occurred using a stethoscope placed just lateral to thyroid 
cartilage. 
• Test 2 (manometer stability) involving observation of the aneroid manometer 
dial as the pressure from the breathing system increased and noting the airway 
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pressure at which the dial reached stability (i.e. the airway pressure at which 
the leak was in equilibrium with fresh gas flow). 
 
Following completion of the above tests the i-gel was removed and any visible blood 
on the device was noted. The trachea of the participant was then intubated with an 
appropriate size tracheal tube (Sims Portex); Size 8.5 was used for the male 
participants and size 7.5 was used for the female participants. The tracheal tube was 
used for the remaining duration of anaesthesia. 
 
The difference between inspired tidal volume (ITV) and expired tidal volume (ETV) 
was used to calculate leak volume (LV) i.e. LV = ITV – ETV. The primary end point 
of our study was difference in the leak fraction between two airway devices under 
investigation. The leak fraction was defined as leak volume divided by inspired tidal 
volume. (i.e. Leak fraction = LV/ITV). 
 
In order to estimate the sample size, we considered a difference in the leak fraction of 
more than 0.20 for the i-gel when compared with the tracheal tube to be clinically 
significant. There is no generally accepted standard for a significant difference in the 
leak fraction in the literature. A previous study has used a difference of 0.25 in the 
leak fraction for power calculation.12 We chose a value of 0.20 following a survey in 
our institute in which the majority of anaesthetists considered less than 0.20 of the 
leak fraction to be clinically insignificant. We used a standard deviation value (0.15) 
for the leak fraction from a previous study performed with conventional LMAs.1 A 
two sample study design, using a t-test for comparison of group means, would 
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therefore require a total of 20 patients for 80% power at a significance level of 5% 
(MINITAB 15.1). 
Secondary outcomes were difference in the leak volume between the i-gel and the 
tracheal tube, airway leak pressures, gastric insufflations, success of first attempt 
insertion, number of manipulations after insertion and the incidence of visible blood 
on removal of the i-gel. 
 
Statistical analysis was performed using MINITAB 15.1 Statistical Software (Minitab 
Inc. State College, USA). The paired data (leak fractions, leak volumes and airway 
leak pressures) were analysed using Wilcoxon signed rank test. 
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Results 
25 patients were recruited to the study. Five patients were excluded for analysis of 
primary end point because of calibration errors of spirometer. The mean (SD) age, 
weight and body mass index of the participants is shown in table 1.  
 
There was no statistically significant difference between the leak fractions of the i-gel 
and the tracheal tube at 15 and 20 cm H2O PCV (p=0.61 and p=0.60 respectively). At 
25 cm H2O PCV the median difference in leak fraction was 0.02 (95% CI 0.002-
0.057; p=0.014). Two of the 20 cases analysed had a difference in leak fraction of 
more than 0.20. This difference was observed at all the pressures used during 
pressure-controlled ventilation (Fig. 1). The volume of gas leak for these two cases 
was more than 200 ml for all pressure settings. The airway leak pressures for these 
two cases were 11 and 15 cm H2O.   
 
On analysis of the volume of gas leak we saw a similar trend (Fig 2). The volume of 
gas leak at PCV 15 and 20 cm H2O was not statistically different between the two 
groups (p=0.11 and p=0.67 respectively). At 25 cm H2O PCV the median difference 
in leak volume was 26.5 ml (95% CI 4.5- 62; p=0.006).  
 
The median (IQR) airway leak pressure for the i-gel was 28 (20-35.5) cm H2O using 
the auscultation method and 28 (20.5-36) cm H2O using the manometer stabilization 
method. There was no statistical difference in the values obtained by using either test 
(p=0.068). Airway leak pressures for all the participants when intubated consistently 
reached 40 cm H2O. 
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None of the participants in our study tested positive for gastric insufflations by 
auscultation over epigastric area. All the i-gels were inserted at the first attempt. Only 
four of the 25 needed minor manipulations after insertion. None of the cases needed 
more than one manipulation. An acceptable airway could be achieved for all the study 
patients using the i-gel. On removal, visible blood was noticed on three i-gels. Two 
other cases had a minor trauma to the lip. 
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Discussion 
 
There are several well-established advantages of using a supraglottic airway device 
(SAD) compared to a tracheal tube. The major ones include lower incidence of sore 
throat13, less hemodynamic upset during induction and maintenance of anaesthesia14 
15, better oxygenation during emergence16 and an increased case turnover17. 
Therefore, recently there has been a trend towards substituting a SAD for a tracheal 
tube for controlled ventilation in patients with a minimal risk of aspiration. The i-gel 
is a relatively new SAD made of gel-like material and does not have an inflatable 
cuff. It is designed to reduce airway morbidity even further. Absence of an inflatable 
cuff means, that theoretically it may be more prone to gas leaks during PCV. Data 
from our study shows that compared to a tracheal tube there is no significant 
difference in the gas leak when using an i-gel in a vast majority of cases. The small 
difference at higher pressure although statistically significant is unlikely to be 
clinically important. 
 
For sample size calculations we assumed that the values of leak fraction would be 
normally distributed. This assumption was found to be incorrect as there were two 
out-liers. In the analysis we included these two out-liers and therefore analysed the 
data using a non-parametric test. Minor variation in the upper airway anatomy might 
be the cause of the clinically significant gas leaks observed in these two out-lier cases. 
This may be because the i-gel relies on normal airway anatomy to provide a good 
airtight seal. 
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The tracheal tube is conventionally used to ventilate the lungs of the patients during 
anaesthesia, therefore any alternative device should be compared to this gold 
standard. We assumed that differences between inspired and expired tidal volumes are 
exclusively attributable to the gas leaks. In fact, a part of the difference may be due to 
the compliance of the breathing system. But this possible confounding factor would 
apply to both the tracheal tube and the i-gel groups.   
 
In this study, we used pressure-controlled mode instead of volume-controlled mode to 
ventilate the patients’ lungs, as the amount of leak volume is affected by the pressure 
generated between the airway device and the supraglottic tissues. Furthermore there is 
evidence to suggest that PCV is more efficient and safer than volume-controlled 
ventilation for controlled ventilation with a SAD.18 
 
We measured airway leak pressure using two methods (Auscultation and Manometer 
stability). A previous study on a conventional SAD showed that, the values obtained 
are similar using either method.19 We found that this also applies to the i-gel. Our 
results suggest that the i-gel achieved a median airway leak pressures of 28 cm H2O 
this is higher than those of the conventional LMA (20 cm H2O) and similar to those of 
Proseal LMA.20 The value of the airway leak pressure for the i-gel in our study is 
comparable to the value quoted in an unpublished study [Paralkar U, Al-Shaikh B, 
Jones M, Dent H. Trustwide Evaluation of the i-gel - Novel Supraglottic Airway]. 
 
There was no evidence of gastric insufflations, regurgitation or aspiration while using 
the i-gel for PCV during our study. We had no cases of failed insertions. The 
incidence of visible blood on the i-gel after removal, in our study, was 12% (3/25). 
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This is similar to those reported with other SAD. The incidence of visible blood with 
use of other SAD has been quoted from 12% to 18%, depending upon the type of 
SAD, the technique of insertion and ease of insertion.21 22 We did not assess the 
anatomical position of the device in relation to vocal cords with fibreoptic 
bronchoscope as it has been shown that anatomical findings do not correlate with the 
clinical consequences.23 24
 
Possible limitations of our study are that it was neither blinded nor randomised, 
although by the use of a crossover design we were able to limit the influence of inter-
patient variability on the comparison. In addition we did not study pressures higher 
than 25 cm H2O that can be associated with laparoscopic procedures. 
 
Our study supports the use of the i-gel for PCV in a vast majority of patients, 
provided pressures can be limited to 25 cm H2O, although there can be large gas leaks 
for a small proportion of patients. Attempts should be made to recognise these soon 
after insertion using spirometry and if the gas leaks are excessive, it should be 
replaced with an alternative device.  
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Table 1 Demographic data. Values are expressed as mean (SD) or actual number 
 
Parameters n=20 
Sex; M: F 
Age; years 
Weight; kg 
Body Mass Index; kg.m-2
4:16 
45.2 (10.5) 
74.1 (12.2) 
27.6 (4.1) 
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Figure 1 Leak fractions. Box shows the median, 25th and 75th percentiles (box 
boundaries), and range (whiskers). * out-lier cases. The difference between the pairs 
at 15 cm H2O PCV (NS), 20 cm H2O PCV (NS), 25 cm H2O PCV significant 
(p=0.014) 
 
Figure 2 Leak Volumes. Box shows the median, 25th and 75th percentiles (box 
boundaries), and range (whiskers). * out-lier cases. The difference between pairs at 15 
cm H2O PCV (NS), 20 cm H2O PCV (NS), 25 cm H2O PCV significant (p=0.006) 
 
 
